19th Annual Superbugs & Superdrugs London, England, UK 20-21 March 2017

Description:
SMi presents the 2017 19th annual Superbugs & Superdrugs conference, taking place on 20 -21 March in Central London.

Expanding horizons on the growing threat of anti-microbial resistance (AMR) for almost two decades, the flagship show in the global Superbugs portfolio of events will once again play host to an international audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities.

The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of speakers

A must attend for both new and seasoned stakeholders involved in AMR and infectious disease, the industry’s premier event will provide a perfect platform for its growing "superbugs" community to network, exchange novel solutions and consolidate current strategies.

FEATURED SPEAKERS:

• Sumathi Nambiar, Dir, Division of Anti-Infective Products, FDA
• Richard Bax, Senior Partner, TranScrip
• Lloyd Czaplewski, Dir, Chemical Biology Ventures
• Chris Houchens, Branch Chief, BARDA
• James Anderson, Head of Corporate Government Affairs, GSK
• Aileen Rubio, Head of Biology, Spero Therapeutics

Prices:
Conference & 2 Workshops: GBP 2697,
Conference & 1 Workshop: GBP 2098,
Conference only: GBP 1499